Surgery Partners Operating Expenses 2013-2024 | SGRY

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Surgery Partners operating expenses from 2013 to 2024. Operating expenses can be defined as the sum of all operating expenses for the given industry.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Surgery Partners operating expenses from 2013 to 2024. Operating expenses can be defined as the sum of all operating expenses for the given industry.

Related Stocks
Company Name	Market Cap
Elevance Health (ELV)	$98B
Cencora (COR)	$48.9B
DiDi Global (DIDIY)	$23.6B
ICON (ICLR)	$17.7B
Natera (NTRA)	$16.6B
Viatris (VTRS)	$15.5B
Avantor (AVTR)	$15.4B
Revvity (RVTY)	$14.9B
BioMerieux (BMXMF)	$13.1B
CochLear (CHEOY)	$12.6B
Solventum (SOLV)	$12.5B
Medpace Holdings (MEDP)	$11.3B
Charles River Laboratories (CRL)	$11B
Doximity (DOCS)	$10.8B
HealthEquity (HQY)	$8.6B
Sonic Healthcare (SKHHY)	$8.5B
Bausch + Lomb (BLCO)	$7B
Life Times (LTH)	$5.2B
Sotera Health (SHC)	$4.6B
Organon (OGN)	$4.1B
BrightSpring Health Services (BTSG)	$3.4B
PACS (PACS)	$3.3B
Alignment Healthcare (ALHC)	$2.6B
Concentras Parent (CON)	$2.5B
Ardent Health Partners (ARDT)	$2.3B
Premier (PINC)	$2.3B
GeneDx Holdings (WGS)	$2.1B
Ryman Healthcare (RYHTY)	$2B
GoodRx Holdings (GDRX)	$1.9B
Teladoc Health (TDOC)	$1.6B